ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Roche signs deal with Dyno Therapeutics for gene therapy vectors
October 16, 2020Roche has signed a collaborative agreement with Dyno Therapeutics for the development of adeno-associated virus (AAV) vectors for gene therapies for central nervous system (CNS) disease and liver-directed therapies. -
Sarepta and Dyno Therapeutics Will Develop Next-Gen Gene Therapy Vectors
May 13, 2020Dyno’s proprietary CapsidMap platform opens up new ways to identify novel capsids. -
Dyno Therapeutics launches with deals from Novartis and Sarepta
May 13, 2020Biotechnology company Dyno Therapeutics has launched from stealth mode with focus on using artificial intelligence (AI) technology to develop adeno-Associated Virus (AAV) vectors.
Pharma Sources Insight January 2025
